This website uses cookies to enhance the user experience.
O

OPNII AS898 988 562

Research
Limited company
Hoslebakken 5 1362 HOSLE, Norge

OPNII AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
12 years
since Oct 16, 2012
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
30
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2023
80,000
NOK
Annual total result 2023
108,300
NOK
Total equity 2023
-3,910,294
NOK
Last update: Aug 29, 2024

Management

Board

NameRoleShares
Contact Person, Chairman
60.76 %
indirectly
Alternate Member
39.24 %
indirectly

Others

NameRoleShares
A
AMESTO ACCOUNTHOUSE SØR AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Contact Person, Chairman
60.76 %
indirectly
Alternate Member
39.24 %
indirectly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
O
OVERSKUDD AS
Ordinary shares
30
100 %

Shares owned by the OPNII AS

NameShare classNumber of sharesShare
N
NETACCOUNT REGNSKAP AS
Ordinary shares
30
100 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 0
    Operating profit 2023: NOK -21,590
    Employees: 0

Financials

in NOK

Summary

Year202320222021
Total operating income
80,000
74,000
0
Annual Total Result
108,300
110,693
-126,844
Total assets
3,072,715
2,789,757
2,539,582
Total liabilities
6,983,009
6,808,351
6,668,869
Total equity
-3,910,294
-4,018,594
-4,129,288

P&L

Year202320222021
Total operating income
80,000
74,000
0
Total operating costs
110,078
114,280
115,131
Operating result
-30,078
-40,280
-115,131
Financial income/costs
138,378
150,974
-11,712
Profit before tax
108,300
110,693
-126,844
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
108,300
110,693
-126,844

Balance overview

Year202320222021
Total fixed assets
1,978,006
1,978,006
1,978,006
Total current assets
1,094,709
811,751
561,576
Total assets
3,072,715
2,789,757
2,539,582
Short term debt
6,284,496
4,632,138
4,033,156
Long term debt
698,513
2,176,213
2,635,713
Total liabilities
6,983,009
6,808,351
6,668,869
Contributed capital
30,000
30,000
30,000
Retained earnings
-3,940,294
-4,048,594
-4,159,288
Total equity
-3,910,294
-4,018,594
-4,129,288
Total equity and liabilities
3,072,715
2,789,757
2,539,582

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology